These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 8543845
1. Adjuvant-free hsp70 fusion protein system elicits humoral and cellular immune responses to HIV-1 p24. Suzue K, Young RA. J Immunol; 1996 Jan 15; 156(2):873-9. PubMed ID: 8543845 [Abstract] [Full Text] [Related]
2. [Influence of JEV E-HSP70 (Mycobacterium tuberculosis) fusion protein on immune response in BALB/c mice]. Ge FF, Qiu YF, Yang YW, Chen PY. Wei Sheng Wu Xue Bao; 2005 Jun 15; 45(3):441-5. PubMed ID: 15989243 [Abstract] [Full Text] [Related]
3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens. Kmieciak D, Bolesta E, Naito T, Gzyl J, Kaneko Y, Kozbor D. J Hum Virol; 2001 Jun 15; 4(6):306-16. PubMed ID: 12082397 [Abstract] [Full Text] [Related]
4. Fusion expression of major antigenic segment of JEV E protein-hsp70 and the identification of domain acting as adjuvant in hsp70. Ge FF, Qiu YF, Gao XF, Yang YW, Chen PY. Vet Immunol Immunopathol; 2006 Oct 15; 113(3-4):288-96. PubMed ID: 16859755 [Abstract] [Full Text] [Related]
5. Endotoxin-minimized HIV-1 p24 fused to murine hsp70 activates dendritic cells, facilitates endocytosis and p24-specific Th1 response in mice. Krupka M, Zachova K, Cahlikova R, Vrbkova J, Novak Z, Sebela M, Weigl E, Raska M. Immunol Lett; 2015 Jul 15; 166(1):36-44. PubMed ID: 26021827 [Abstract] [Full Text] [Related]
14. Prophylactic, therapeutic and anti-metastatic effects of an HPV-16mE6Delta/mE7/TBhsp70Delta fusion protein vaccine in an animal model. Qian X, Lu Y, Liu Q, Chen K, Zhao Q, Song J. Immunol Lett; 2006 Feb 15; 102(2):191-201. PubMed ID: 16242781 [Abstract] [Full Text] [Related]
15. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus. Ge FF, Qiu YF, Yang YW, Chen PY. Arch Virol; 2007 Jan 15; 152(1):125-35. PubMed ID: 16862385 [Abstract] [Full Text] [Related]
16. Development of BCG as a live recombinant vector system: potential use as an HIV vaccine. Fuerst TR, Stover CK, de la Cruz VF. Biotechnol Ther; 1991 Jan 15; 2(1-2):159-78. PubMed ID: 1845119 [Abstract] [Full Text] [Related]
17. A truncated C-terminal fragment of Mycobacterium tuberculosis HSP70 gene enhanced potency of HBV DNA vaccine. Li X, Yang X, Li L, Liu H, Liu J. Vaccine; 2006 Apr 12; 24(16):3321-31. PubMed ID: 16472546 [Abstract] [Full Text] [Related]
18. Hemagglutinating virus of Japan protein is efficient for induction of CD4+ T-cell response by a hepatitis B core particle-based HIV vaccine. Takeda S, Shiosaki K, Kaneda Y, Nakasatomi T, Yoshizaki H, Someya K, Konno Y, Eda Y, Kino Y, Yamamoto N, Honda M. Clin Immunol; 2004 Jul 12; 112(1):92-105. PubMed ID: 15207786 [Abstract] [Full Text] [Related]
19. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells. Hinkula J, Walther-Jallow L, Laurén A, Mäkitalo B, Oberg M, Wahren B, Fenyö EM, Spetz AL. Vaccine; 2009 Oct 30; 27(46):6424-31. PubMed ID: 19549607 [Abstract] [Full Text] [Related]
20. Feeding of mice with Arabidopsis thaliana expressing the HIV-1 subtype C p24 antigen gives rise to systemic immune responses. Lindh I, Kalbina I, Thulin S, Scherbak N, Sävenstrand H, Bråve A, Hinkula J, Strid A, Andersson S. APMIS; 2008 Nov 30; 116(11):985-94. PubMed ID: 19132995 [Abstract] [Full Text] [Related] Page: [Next] [New Search]